GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (STU:UTH) » Definitions » Investments And Advances

United Therapeutics (STU:UTH) Investments And Advances : €1,373 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is United Therapeutics Investments And Advances?

United Therapeutics's Investments And Advances for the quarter that ended in Mar. 2024 was €1,373 Mil.

United Therapeutics's quarterly Investments And Advances declined from Sep. 2023 (€1,931 Mil) to Dec. 2023 (€1,751 Mil) and declined from Dec. 2023 (€1,751 Mil) to Mar. 2024 (€1,373 Mil).

United Therapeutics's annual Investments And Advances declined from Dec. 2021 (€1,460 Mil) to Dec. 2022 (€1,242 Mil) but then increased from Dec. 2022 (€1,242 Mil) to Dec. 2023 (€1,751 Mil).


United Therapeutics Investments And Advances Historical Data

The historical data trend for United Therapeutics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Investments And Advances Chart

United Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 690.75 944.97 1,460.16 1,242.49 1,751.29

United Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,649.07 1,867.78 1,930.97 1,751.29 1,372.55

United Therapeutics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


United Therapeutics (STU:UTH) Business Description

Traded in Other Exchanges
Address
1040 Spring Street, Silver Spring, MD, USA, 20910
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (STU:UTH) Headlines

No Headlines